Cysteine ??Protease Inhibitors Proteasome inhibitors Gamma-secretase inhibitors MMP inhibitors HCV Protease Inhibitors HIV Protease Inhibitors DPP-4 inhibitors DUB inhibitors Serine Protease Inhibitors BACE inhibitors
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors >  Proteases

Proteases

Cysteine ??Protease Inhibitors Proteasome inhibitors Gamma-secretase inhibitors MMP inhibitors HCV Protease Inhibitors HIV Protease Inhibitors DPP-4 inhibitors DUB inhibitors Serine Protease Inhibitors BACE inhibitors
More
Less

Proteases are the major pathway in the degradation of misfolded protein in protein synthesis and other proteolyzed protein, which are found in all eukaryotic cells, archaea, and some bacteria. Proteases, composed of plural Catalytic protein and regulatory protein, have multiple catalytic activities. It has three to four kinds of different peptidase activities, including the hydrolysis activity of tryptase, chymotrypsin-like enzyme and peptidylglutamyl-peptide. Depending on the sedimentation coefficient, it can be divided into two types of proteases: the 26S proteasome, of which the molecular weight is about 2000 kDa, dependent on ATP; and 20S proteasome, of which relative molecular mass of about 750 kDa, independent on ATP. The degradation of most protein by the proteasome requires ubiquitination.

26s proteasome is a multi-subunit protease of 2-MDa, which can degrade most of the cytoplasm, endoplasmic reticulum and nucleoprotein. The most understood target protein degradation mechanism is ubiquitin degradation via ubiquitin, an 8-kDa protein. 26s proteasome is composed of a core protein of 20s and the regulatory complex composition of 19s .The chaperone of 19s can unfold ubiquitin-labeled protein substrate and send it into the graphics core of 20s, where there are three pairs of proteolytic active sites, whose names are corresponding to the specific similarity to the cleavage specificity of chymotrypsin, trypsin and caspase. Studies on bud yeast mutants ultimately suggest the different role of these three pairs of sites. And the chymotrypsin-like active sites are most crucial to normal and regular growth. Proteasome inhibitors have been applied in the treatment of diseases such as cancer as well as widely used in laboratory studies. MG-341 is an FDA-approved medication for multiple myeloma and mantle cell lymphoma. It can also be used in laboratory studies to inhibit the activity of proteasome. Other protease inhibitors including disulfiram, epigallocatechin-3-gallate, salinosporamide A, carfilzomib, ONX0912, CEP-18770 and MLN9708 have also been developed or are in clinical trials for drugs and testing phase.

MG132, also known as Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal, Z-LLL-CHO, is a peptide aldehyde, capable of inhibiting the activity of different types of proteases, including serine proteases and calpains. MG132 and other peptide aldehydes can effectively inhibit the protease activity of several peptidases in Proteasome as well as the activity of calpains.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
Carfilzomib
CAS:
868540-17-4
MF:
C40H57N5O7
Structure:
Chemical Name:
MG-132
CAS:
133407-82-6
MF:
C26H41N3O5
Structure:
Chemical Name:
DAPT
CAS:
208255-80-5
MF:
C23H26F2N2O4
Structure:
Chemical Name:
Telaprevir
CAS:
402957-28-2
MF:
C36H53N7O6
Structure:
Chemical Name:
Doxycycline hydrochloride
CAS:
10592-13-9
MF:
C22H25ClN2O8
Structure:
Chemical Name:
Nelfinavir mesylate
CAS:
159989-65-8
MF:
C33H49N3O7S2
Structure:
Chemical Name:
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA)
CAS:
850649-61-5
MF:
C18H21N5O2
Structure:
Chemical Name:
Nafamostat mesylate
CAS:
82956-11-4
MF:
C21H25N5O8S2
Structure:
Chemical Name:
Daclatasvir
CAS:
1009119-64-5
MF:
C40H50N8O6
Structure:
Chemical Name:
Ledipasvir
CAS:
1256388-51-8
MF:
C49H54F2N8O6
Structure:
Chemical Name:
Semagacestat
CAS:
425386-60-3
MF:
C19H27N3O4
Structure:
Chemical Name:
EST
CAS:
88321-09-9
MF:
C17H30N2O5
Structure:
Chemical Name:
Omarigliptin (MK-3102)
CAS:
1226781-44-7
MF:
C17H20F2N4O3S
Structure:
Chemical Name:
Avagacestat (BMS-708163)
CAS:
1146699-66-2
MF:
C20H17ClF4N4O4S
Structure:
Chemical Name:
Darunavir ethanolate
CAS:
635728-49-3
MF:
C29H43N3O8S
Structure:
Chemical Name:
DIBENZAZEPINE
CAS:
209984-56-5
MF:
C26H23F2N3O3
Structure:
Chemical Name:
Danoprevir
CAS:
850876-88-9
MF:
C35H46FN5O9S
Structure:
Chemical Name:
cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid
CAS:
471905-41-6
MF:
C21H21ClF2O4S
Structure:
Chemical Name:
CJC1295
CAS:
863288-34-0
MF:
C152H252N44O42
Structure:
Chemical Name:
AZD 9668
CAS:
848141-11-7
MF:
C25H22F3N5O4S
Structure:
Chemical Name:
Ilomastat
CAS:
142880-36-2
MF:
C20H28N4O4
Structure:
Chemical Name:
RO4929097
CAS:
847925-91-1
MF:
C22H20F5N3O3
Structure:
Chemical Name:
Teneligliptin Hydrobromide
CAS:
906093-29-6
MF:
C22H31BrN6OS
Structure:
Chemical Name:
Batimastat
CAS:
130370-60-4
MF:
C23H31N3O4S2
Structure:
Chemical Name:
LY411575
CAS:
209984-57-6
MF:
C26H23F2N3O4
Structure:
Chemical Name:
ONX-0914
CAS:
960374-59-8
MF:
C31H40N4O7
Structure:
Chemical Name:
Cathepsin Inhibitor 1
CAS:
225120-65-0
MF:
C20H24ClN5O2
Structure:
Chemical Name:
PD 151746
CAS:
179461-52-0
MF:
C11H8FNO2S
Structure:
Chemical Name:
Marimastat
CAS:
154039-60-8
MF:
C15H29N3O5
Structure:
Chemical Name:
PI-1840
CAS:
1401223-22-0
MF:
C22H26N4O3
Structure:
Chemical Name:
CEP-18770
CAS:
847499-27-8
MF:
C21H28BN3O5
Structure:
Chemical Name:
E-64C
CAS:
76684-89-4
MF:
C15H26N2O5
Structure:
Chemical Name:
CALPEPTIN
CAS:
117591-20-5
MF:
C20H30N2O4
Structure:
Chemical Name:
MK-0822
CAS:
603139-19-1
MF:
C25H27F4N3O3S
Structure:
Chemical Name:
VX-222
CAS:
1026785-59-0
MF:
C25H35NO4S
Structure:
Chemical Name:
Oprozomib
CAS:
935888-69-0
MF:
C25H32N4O7S
Structure:
Chemical Name:
Trelagliptin
CAS:
865759-25-7
MF:
C18H20FN5O2
Structure:
Chemical Name:
Calpain Inhibitor I
CAS:
110044-82-1
MF:
C20H37N3O4
Structure:
Chemical Name:
(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid
CAS:
1072833-77-2
MF:
C14H19BCl2N2O4
Structure:
Chemical Name:
MLN9708
CAS:
1201902-80-8
MF:
C20H23BCl2N2O9
Structure:
Chemical Name:
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide
CAS:
7497-07-6
MF:
C12H15Cl2NO
Structure:
Chemical Name:
FLI-06
CAS:
313967-18-9
MF:
C25H30N2O5
Structure:
Chemical Name:
MMP-2/MMP-9 INHIBITOR IV
CAS:
292605-14-2
MF:
C15H14O3S2
Structure:
Chemical Name:
Z-PHE-DL-ALA-FLUOROMETHYLKETONE
CAS:
197855-65-5
MF:
C21H23FN2O4